English
As the biopharmaceutical field continues to evolve, the cell factory, a multi-layer structure cell culture vessel, is increasingly becoming the primary tool for large-scale cell culture. Its unique advantage lies in the multi-layer structure design and the equipped specialized piping system, which improves productivity and reduces the risk of exogenous sources.
1. Multi-layer structure advantage:
The cell factory adopts a multi-layer structure design, which effectively increases the culture area by stacking layers on top of each other, making it possible to accommodate more cell cultures in the same space. This design not only saves the production site, but also enables large-scale cell culture to meet the demand for large quantities of cells in fields such as biopharmaceuticals and vaccine production.
2. Dedicated piping system:
The cell factory is equipped with a dedicated piping system that realizes the airtight transfer of liquids. This system can effectively reduce the risk of exogenous contamination during operation and ensure the cleanliness and safety of the production process. At the same time, the dedicated piping system can also realize precise measurement and automatic transfer of liquids, which improves production efficiency, reduces the need for manual operation and lowers the possibility of human error.
3. Efficient production:
Cellular plants with piping make the production process more efficient. Production personnel can transfer between different levels of containers in an airtight manner, avoiding the risk of cross-contamination and damage during the cell culture process. This efficient production mode not only improves the production efficiency, but also ensures the quality and stability of the product.
In summary, the cell factory with piping realizes the high efficiency, safety and controllability of the production process through the design of multi-layer structure and the equipping of special piping system. It will continue to play an important role in the fields of biopharmaceuticals and vaccine production, providing strong support and guarantee for the development and progress of the industry.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.